Livtencity is a prescription medicine used to treat cytomegalovirus (CMV) infection and disease in adults and children 12 years of age and older weighing at least 77 pounds (35 kg) who have received a transplant, when their infection or disease does not respond to treatment with the medicines ganciclovir, valganciclovir, cidofovir or foscarnet. It is not known if Livtencity is safe and effective in children under 12 years of age.
Before taking LIVTENCITY, tell your healthcare provider about all your medical conditions, including if you:
are pregnant or plan to become pregnant. It is not known if LIVTENCITY will harm your unborn baby.
are breastfeeding or plan to breastfeed. It is not known if LIVTENCITY passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with LIVTENCITY.
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. LIVTENCITY may affect the way other medicines work, and other medicines may affect how LIVTENCITY works and cause serious side effects.
Especially tell your healthcare provider if you take a seizure (anticonvulsant) medicine.
Do not start a new medicine without telling your healthcare provider. Your healthcare provider will tell you if it is safe to take LIVTENCITY with other medicines.
What are the possible side effects of LIVTENCITY?
The most common side effects of LIVTENCITY include:
changes in taste
nausea
diarrhea
vomiting
tiredness
These are not all the possible side effects of LIVTENCITY. Call your doctor for medical advice about side effects.
For additional safety information, click for Patient Information and discuss with your HCP.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
What is LIVTENCITY?
LIVTENCITY is a prescription medicine used to treat cytomegalovirus (CMV) infection and disease in adults and children 12 years of age and older weighing at least 77 pounds (35 kg) who have received a transplant, when their infection or disease does not respond to treatment with the medicines ganciclovir, valganciclovir, cidofovir or foscarnet. It is not known if LIVTENCITY is safe and effective in children under 12 years of age.
Important Safety Information
Before taking LIVTENCITY, tell your healthcare provider about all your medical conditions, including if you:
are pregnant or plan to become pregnant. It is not known if LIVTENCITY will harm your unborn baby.
are breastfeeding or plan to breastfeed. It is not known if LIVTENCITY passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with LIVTENCITY.
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. LIVTENCITY may affect the way other medicines work, and other medicines may affect how LIVTENCITY works and cause serious side effects.
Especially tell your healthcare provider if you take a seizure (anticonvulsant) medicine.
Do not start a new medicine without telling your healthcare provider. Your healthcare provider will tell you if it is safe to take LIVTENCITY with other medicines.
What are the possible side effects of LIVTENCITY?
The most common side effects of LIVTENCITY include:
changes in taste
nausea
diarrhea
vomiting
tiredness
These are not all the possible side effects of LIVTENCITY. Call your doctor for medical advice about side effects.
For additional safety information, click for Patient Information and discuss with your HCP.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
What is LIVTENCITY?
LIVTENCITY is a prescription medicine used to treat cytomegalovirus (CMV) infection and disease in adults and children 12 years of age and older weighing at least 77 pounds (35 kg) who have received a transplant, when their infection or disease does not respond to treatment with the medicines ganciclovir, valganciclovir, cidofovir or foscarnet. It is not known if LIVTENCITY is safe and effective in children under 12 years of age.
